Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $154.6500 (1.25%) ($151.6600 - $154.7400) on Mon. Sep. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.15% (three month average) | RSI | 79 | Latest Price | $154.6500(1.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(59%) DIA(53%) IBB(49%) SPLV(48%) VYM(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.575% in a week (0% probabilities). VXX(-33%) VIXM(-31%) USO(-23%) TBT(-19%) BNDX(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.575% (StdDev 1.15%) | Hourly BBV | 1.7 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $153.58(0.7%) | 10 Day Moving Average | $152.87(1.16%) | 20 Day Moving Average | $150.43(2.81%) | To recent high | 0% | To recent low | 16.7% | Market Cap | $272.846b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |